Details

Autor(en) / Beteiligte

• Fuss, Ivan J.
• Friend, Julia
• Yang, Zhiqiong
• He, Jian Ping
• Hooda, Lubna
• Boyer, James
• Xi, Liqiang
• Raffeld, Mark
• Kleiner, David E.
• Heller, Theo
• Strober, Warren

Titel

Nodular Regenerative Hyperplasia in Common Variable Immunodeficiency

Ist Teil von

• Journal of clinical immunology, 2013-05, Vol.33 (4), p.748-758

Ort / Verlag

Boston: Springer US

Erscheinungsjahr

2013

Quelle

SpringerLink

Beschreibungen/Notizen

• Purpose Patients with Common Variable Immunodeficiency (CVID) are subject to the development of a liver disease syndrome known as nodular regenerative hyperplasia (NRH). The purpose of this study was to define the characteristics and course of this complication of CVID. Methods CVID patients were evaluated by retrospective and prospective clinical course review. Liver biopsy specimens were evaluated for evidence of NRH and studied via RT-PCR for cytokine analysis. Results NRH in our CVID patient population occurred in approximately 5 % of the 261 patients in our total CVID study group, initially presenting in most cases with an elevated alkaline phosphatase level. While in some patients the disease remained static, in a larger proportion a more severe disease developed characterized by portal hypertension, the latter leading to hypersplenism with neutropenia and thrombocytopenia and, in some cases, to ascites. In addition, a substantial proportion of patients either developed or presented initially with an autoimmune hepatitis-like (AIH-like) liver disease that resulted in severe liver dysfunction and, in most cases to death due to infections. The liver histologic findings in these AIH-like patients were characterized by underlying NRH pattern with superimposed interface hepatitis, lymphocytic infiltration and fibrosis. Immunologic studies of biopsies of NRH patients demonstrated the presence of infiltrating T cells producing IFN-γ, suggesting that the NRH is due to an autoimmune process. Conclusion Overall, these studies provide evidence that NRH may not be benign but, can be a severe and potentially fatal disease complication of CVID that merits close monitoring and intervention.